Moving forward, it will be critical to identify the core transcriptional and chromatin remodeling dependencies that sustain NC across contexts, and to investigate whether rare SOX2-positive subpopulations contribute to tumor heterogeneity, therapeutic resistance, or recurrence. The gene discussed is SOX2; the disease is neoplasm.